TRANSLARNA 1000 mg, granules for oral suspension 30 sachets
Active ingredients: Ataluren
Commercialized according to BDPMDispensing in France: Prescription only
Granules for oral suspension30 sachetsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TRANSLARNA 1000 mg, granulés pour suspension buvable
- Pharmaceutical form
- granulés pour suspension buvable
- Route of administration
- orale
- Presentation description
- 30 sachet(s) aluminium
- Marketing authorisation holder
- PTC THERAPEUTICS INTERNATIONAL (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 28 Mar 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68469328CIP72795937CIP133400927959370Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ATALURENgranulés | 1000 mg · un sachet | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.